Horizon is a cell engineering company that provides gene editing, modulation and screening services for research and clinical applications.
Business Model:
Revenue: $76.4M
Employees: 201-500
Horizon was acquired by
PerkinElmer.
The acquisition happend on 2020-11-02.
Details of the transaction were not public
Address: 8100 Cambridge Research Park
City: Cambridge
State: england
Zip: CB25 9TL
Country: GB
Horizon is a cell engineering company that provides gene editing, modulation and screening services for research and clinical applications.
Contact Phone:
Contact Email:
Listed Exchange:
London Stock Exchange
IPO Date:
3/28/2014
Ticker Symbol:
HZD
Amount Raised:
$114M
Opened: -/share
EBITDA | - |
Total Cash | - |
Total Debt | - |
Total Revenue | - |
Total Profit (Gross) | - |
PE Ratio | - |
Announced Date | Company | Transaction | Money Raised |
---|---|---|---|
7/2017 | Sphere Fluidics | Grant | 0 |
7/2017 | Sphere Fluidics | Grant | 0 |
Announced Date | Name | Price |
---|---|---|
7/2017 | Dharmacon | |
1/2015 | Haplogen Genomics GmbH | |
9/2014 | SAGE Labs | |
6/2014 | CombinatoRx | |
5/2010 | Horizon Discovery Services Ltd. |
|
Revenue: 0 - 100000 Employees: Industry: Software |
Details
|
|
Revenue: 0 - 100000 Employees: 51 - 500 Industry: Education |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Blockchain |
Details
|
|
Revenue: 0 - 100000 Employees: 11 - 50 Industry: Industrial |
Details
|
|
Revenue: 0 - 100000 Employees: 1 - 10 Industry: Advertising |
Details
|